Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Eris Lifesciences Ltd.
Swot
Eris Lifesciences Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Eris Lifesciences Ltd. has 19 Strengths, 10 Weaknesses, 4 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(19)
Weakness
(10)
Opportunity
(4)
Threats
(0)
Others
(2)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Strong Momentum: Price above short, medium and long term moving averages
Consistent Highest Return Stocks over Five Years
Expensive Rockets (DVM)
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
PEG lower than Industry PEG
Stocks gaining versus previous close, open price and RSI
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Book Value per share Improving for last 2 years
Near 52 Week High
RSI indicating price strength
High Volume, High Gain
Top Gainers
Volume Shockers
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter
Promoter decreasing their shareholding
PE higher than Industry PE
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Performance of Stocks with Low Trendlyne Durability Score versus Benchmarks
Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
High promoter stock pledges
Brokers upgraded recommendation or target price in the past three months
FII / FPI or Institutions increasing their shareholding
MFs increased their shareholding last quarter
Mutual Funds Increased Shareholding over the Past Two Months
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
Decline in Net Profit with falling Profit Margin (QoQ)
